The Use of Biokinetics and In Vitro Methods in Toxicological Risk Evaluation: The Report and Recommendations of ECVAM Workshop 15

ATLA Alternatives to Laboratory Animals

Volumn 24, Issue 4, 1996, Pages 473-497

  Blaauboer, Bas J ^a   Bayliss, Martin K ^b   Castell, José V ^c   Evelo, Chris T A ^d   Frazier, John M ^e   Groen, Kees ^f   Gülden, Michael ^g   Guillouzo, André ^h   Hissink, Arendina M ⁱ   Houston, J Brian ^j   Johanson, Gunnar ^k   De Jongh, Joost ^a   Kedderis, Gregory L ^l   Reinhardt, Christoph A ^m   Van De Sandt, Johannes J M ⁱ   Semino, Giovanna ⁿ  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GLAXOSMITHKLINE   (United Kingdom)

^c HOSPITAL UNIVERSITARIO LA FE   (Spain)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e AIR FORCE RESEARCH LABORATORY   (United States)

^f JANSSEN RESEARCH FOUNDATION   (Belgium)

^g UNIVERSITY OF KIEL   (Germany)

^h PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

ⁱ TNO   (Netherlands)

^j UNIVERSITY OF MANCHESTER   (United Kingdom)

^k NATIONAL INSTITUTE FOR WORKING LIFE   (Sweden)

^l CIIT CENTERS FOR HEALTH RESEARCH   (United States)

^m Swiss Alternatives to Animal Testing   (Switzerland)

ⁿ UNIVERSITY OF MILAN   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000806003     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (82)

1. Anon. (1994). ECVAM News & Views. ATLA 22, 7-11.
2. Blaauboer, B.J. (1995). The use of hepatocyte cultures in pharmacology and toxicology. In Proceedings of an EU Meeting on Hepatocyte-based In Vitro Models and their Application in Pharmacotoxicology, pp. 1-9. Brussels: VUB Press.
3. Walum, E., Balls, M., Bianchi, V., Blaauboer, B., Bolcsfoldi, G., Guillouzo, A., Moore, G.A., Odland, L., Reinhardt, C. & Spielmann, H. (1992). ECITTS: an integrated approach to the application of in vitro test systems to the hazard assessment of chemicals. ATLA 20, 406-428.
4. Blaauboer, B.J., Balls, M., Bianchi, V., Bolcsfoldi, G., Guillouzo, A., Moore, G.A., Odland, L., Reinhardt, C.A., Spielmann, H. & Walum, E. (1994). The ECITTS integrated toxicity testing scheme: the application of in vitro test systems to the hazard assessment of chemicals. Toxicology in Vitro 8, 845-846,
5. Barratt, M.D., Castell, J.V., Chamberlain, M., Combes, R.D., Dearden, J.C., Fentem, J.H., Gerner, I., Guiliuani, A., Gray, T.J.B., Livingstone, D.J., Provan, W M., Rutten, F.A.J.J.L., Verhaar, H.J.M. & Zbinden, P. (1995). The integrated use of alternative approaches for predicting toxic hazard. The report and recommendations of ECVAM workshop 8. ATLA 23, 410-429.
6. Andersen, M.E. & Krishnan, K. (1994). Physiologically based pharmacokinetic modelling in toxicology. In Principles and Methods of Toxicology, 3rd edn (ed. A. W. Hayes), pp. 149-188. New York: Raven Press.
7. Sato, A. & Nakajima, T. (1979). A structure-activity relationship of some chlorinated hydrocarbons. Archives of Environmental Health 79, 69-75.
8. Fiserova-Bergerova, V. & Diaz, M.L. (1986). Determination and prediction of tissue-gas partition coefficients. International Archives of Occupational and Environmental Health 58, 75-87.
9. Gargas, M.L., Burgess, R.J., Voisard, D.E., Cason, G.H. & Andersen, M.E. (1989). Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicology and Applied Pharmacology 98, 87-99.
10. Pacifici, G.M. & Viani, A, (1992). Methods of determining plasma and tissue binding of drugs. Clinical Pharmacokinetics 23, 449-468.
11. Jepson, G.W., Hoover, D.K., Black, R.K., McCafferty, J.D., Mahle, D.A. & Gearhart, J M. (1994), A partition coefficient determination method for non-volatile chemicals in biological tissues. Fundamental and Applied Toxicology 22, 519-524.
12. Patterson. S. & Mackay, D. (1989). Correlation of tissue, blood and air partition coefficients of volatile organic chemicals. British Journal of Industrial Medicine 46, 321-328.
13. Poulin, P. & Krishnan, K. (1995). A biologicallybased algorithm for predicting human tissue-blood partition coefficients of organic chemicals. Human and Experimental Toxicology 14, 273-280.
14. max) of halogenated methanes, ethanes and ethylenes. Toxicology Letters 43, 235-256.
15. Connell, DW., Braddock, R.D. & Mani, S.V. (1993). Prediction of the partition coefficient of lipophilic compounds in the air-mammal tissue system. Science of the Total Environment Suppl. 2, 1383-1396.
16. Chou, J.T. & Jurs, P.C. (1980). Computation of partition coefficients from molecular structures by a fragment addition method. In Physical and Chemical Properties of Drugs (ed. S.H. Yalkowsky, A.A. Sinkula & S.C. Valvani), pp. 163-199. New York: Marcel Dekker.
17. Kier, L.B. (1980). Molecular connectivity as a descriptor of structure for SAR analysis In Physical and Chemical Properties of Drugs (ed. S.H. Yalkowsky, A.A. Sinkula & S.C. Valvani), pp. 277-319. New York: Marcel Dekker.
18. Jackson, J. (1987). Drug transport across gastrointestinal epithelia. In Physiology of the Gastrointestinal Tract, 2nd edn. (ed. L.R. Johnson), pp. 1597-1621. New York: Raven Press.
19. Spiller, R.C. (1994). Intestinal absorptive function. Gut 35, Suppl. 1, S5-S9.
20. Scheman, M. & Ehrlein, H.J. (1986). Postprandial patterns of canine jejunal motility and transit of luminal content. Gastroenterology 90, 991-1000.
21. Houston, J.B., Upshall, D.J. & Bridges, J.W. (1974) A re-evaluation of the importance of partition coefficients in the gastrointestinal absorption of nutrients. Journal of Pharmacology and Experimental Therapeutics 189, 244-254.
22. Clewell, H.J. 3rd & Jarnot B.J. (1994). Incorporation of pharmacokinetics in non-cancer risk assessment: example with chloropentafluorobenzene. Risk Analysis 14, 265-276.
23. Ramsey, C.J. & Andersen, M.E. (1994). A physiologically-based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicology and Applied Pharmacology 73, 159-175.
24. Staats, D.A., Fisher, J.W. & Connolly, R.B. (1991). Gastrointestinal absorption of xenobiotics in physiologically-based pharmacokinetic models: a two-compartment description. Drug Metabolism and Disposition 19, 144-148.
25. Semino, G., Lilly, P.D. & Andersen, M.E. (1995). A multi-compartment sequential transport model of the gastrointestinal absorption. The Toxicologist 15, 273 (abstract).
26. Frederick, C.B., Potter, D.W., Chang-Mateau, M.I. & Andersen, M.E. (1992). A physiologically based pharmacokinetic and pharmacodynamic model to describe the oral dosing of rats with ethylacrylate and its implication for risk assessment. Toxicology and Applied Pharmacology 114, 246-260.
27. Bischoff, K.B, Dedrick, R.L., Zaharko, D.S. & Longsreth, J.A. (1971). Methotrexate pharmacokinetics. Journal of Pharmaceutical Sciences 60, 1128-1133.
28. Farris, F.F., Dedrick, R.L., Allen, P.V & Smith, J.C. (1993). Physiological model for pharmacokinetics of methylmercury in the growing rat. Toxicology and Applied Pharmacology 119, 74-90.
29. Leibnovitz, A., Stinson, J.C., McCombs, C.E., Masur, K.C. & Mabry, N.D. (1976). Classification of human colorectal adenocarcinoma cell lines. Cancer Research 36, 4562-4569.
30. Hidalgo, I.J., Raub T.J. & Borchardt R.T. (1989). Characterisation of the human colon carcinoma cell line (CaCo-2) as a model system for intestinal epithelial permeability. Gastroenterology 96, 736-749.
31. Wils, P., Warnery A., Phung-Ba, V. & Scherman, D. (1994). Differentiated intestinal epithelial cell lines as in vitro models for predicting the intestinal absorption of drugs. Cell Biology and Toxicology 10, 393-397.
32. Artusson, P. & Karlsson, J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications 175, 880-885.
33. Fiserova-Bergerova, V., ed. (1983). Modelling of Inhalation Exposure to Vapors: Uptake, Distribution and Elimination. 166 pp. Boca Raton, FL, USA: CRC Press.
34. Gargas, M., Medlinsky, M A. & Andersen, M.E. (1993). Advances in physiological modelling approaches for understanding the disposition of inhaled vapors. In Toxicology of the Lung (ed. D.E. Gardner, J.D. Crapo & R.O. McClellan), pp. 461-483. New York: Raven Press.
35. Johanson, G. (1991). Modelling of respiratory exchange of polar solvents. Annals of Occupational Hygiene 35, 323-339.
36. Medinsky, M.A, Kimbress, J.S., Morris, J.B., Gerde, P. & Overton, J.H. (1993). Advances in biologically based models for respiratory tract uptake of inhaled volatiles. Fundamental and Applied Toxicology 20, 265-272.
37. Gerde, P. & Dahl, A.R. (1991) A model for the uptake of inhaled vapors in the nose of the dog during cyclic breathing. Toxicology and Applied Pharmacology 109, 276-288.
38. Tsu, M.E., Babb, A.L., Sugiyama, E.M. & Hlastala, M.O. (1991). Dynamics of soluble gas exchange in the airways. II. Effects of breathing conditions. Respiratory Physiology 83, 261-276.
39. Morris, J.B. (1990). First-pass metabolism of inspired ethyl acetate in the upper respiratory tracts of the F344 rat and Syrian hamster. Toxicology and Applied Pharmacology 102, 331-345
40. Morris, J.B., Clay, R.J. & Cavanagh. D.G. (1986). Species differences in upper respiratory tract deposition of acetone and ethanol vapors. Fundamental and Applied Toxicology 7, 671-680.
41. Johanson, G. & Filser, J.G. (1992). Experimental data from closed chamber gas uptake studies in rodents suggest lower uptake rate of chemical than calculated from literature values on alveolar ventilation. Archives of Toxicology 66, 291-295.
42. Anon. (1966). Disposition and retention models for internal dosimetry of the human respiratory tract (Task Group on Lung Dynamics), Health Physics 12, 173-207.
43. Snipes, M.B (1995). Pulmonary retention of particles and fibers: biokinetics and effects of exposure concentrations. In Concepts in Inhalation Toxicology (ed. R.O. McClellan & R.F. Henderson), pp. 225-255. Washington, DC: Taylor & Francis.
44. Overton, J.H. (1984). Physicochemical processes and the formulation of dosimetry models. Journal of Toxicology and Environmental Health 13, 273-294
45. Gerde, P., Muggenburg, B.A. & Henderson, R.F. (1993). Disposition of polycyclic aromatic hydrocarbons in the respiratory tract of the Beagle dog. III. Mechanisms of dosimetry. Toxicology and Applied Pharmacology 121, 328-334.
46. Gerde, P., Medinsky, M.A. & Bond, J.A. (1991). Particle-associated polycyclic aromatic hydrocarbons: a reappraisal of their possible role in pulmonary carcinogenesis. Toxicology and Applied Pharmacology 108, 1-13.
47. Howes, D., Guy, R., Hadgraft, J., Heylings, J., Hoeck, U., Kemper, F., Maibach, H., Marty, J P., Merk, H., Parra, J., Rekkas, D., Rondelli, I., Schaefer, H., Täuber, U. & Verbiese, N. (1996). Methods for assessing percutaneous absorption. The report and recommendations of ECVAM workshop 13. ATLA 24. 81-106.
48. Forslind, B. (1994). A domain mosaic model of the skin barrier Acta Dermato-Venereologica (Stockholm) 74, 1-6.
49. Friend, D.R (1992). In vitro permeation techniques. Journal of Controlled Release 18, 235-248.
50. van de Sandt, J.J.M., Rutten, A.A.J.J.L. & van Ommen, B (1993). Species specific cutaneous biotransformation of the pesticide propoxur during percutaneous absorption in vitro. Toxicology and Applied Pharmacology 123, 144-150.
51. Riviere, J.E., Bowman, K.F , Monteiro-Riviere, N.A., Dix, L P. & Carver. M P. (1986). The isolated perfused porcine skin flap (IPPSF). I. A novel in vitro model for percutaneous absorption and cutaneous toxicology studies. Fundamental and Applied Toxicology 7, 444-453.
52. Mattie, D.R., Bates, G.D. Jr, Jepson G.W., Fisher, J.W. & McDougal, J.N. (1994). Determination of skin-air partition coefficients for volatile chemicals: experimental method and applications. Fundamental and Applied Toxicology 22, 51-57.
53. Barratt, M.D. (1995). Quantitative structureactivity relationships for skin permeability. Toxicology in Vitro 9, 27-37.
54. Potts, R.O., McNeill, S C., Desbonnet, C.R. & Wakshull, E. (1989) Transdermal drug transport and metabolism II. The role of competing kinetic events. Pharmaceutical Research 6, 119-124.
55. Riviere, J.E. & Williams, P.L. (1992). Pharmacokinetic implications of changing blood flow in skin. Journal of Pharmaceutical Sciences 81, 601-602
56. Auton, T R., Westhead, D.R., Woollen, B.H., Scott, R.C. & Wilks, M.F. (1994). A physiologically based mathematical model of dermal absorption in man. Human and Experimental Toxicology 13, 51-60.
57. Joo, F. (1993). The blood-brain barrier in vitro: the second decade. Neurochemistry International 23, 499-521.
58. Pardridge, W., ed. (1993). The Blood-Brain Barrier. Cellular and Molecular Biology. 357 pp. New York: Raven Press.
59. Heller, N., Gloor, S. & Reinhardt, C.A. The blood-brain barrier in vitro: characterisation and potential use for pharmacotoxicological screening In Vitro Toxicology, in press.
60. Selig, A., Gottschlich, R. & Devant, R.M. (1994). A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proceedings of the National Academy of Sciences of the USA 91, 68-72.
61. van Bree, J.B.M.M., De Boer, A.G., Danhof, M., Ginsel, L.A. & Breimer, D.D. (1988). Characterisation of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs. Journal of Pharmacology and Experimental Therapeutics 247, 1233-1239.
62. Joly, B., Fardel, O, Cecchelii, R., Chesné, C., Puozzo, C. & Guillouzo, A. (1995). Selective drug transport and P-glycoprotein activity in an in vitro blood-brain barrier model. Toxicology in Vitro 9, 357-364.
63. Dehouck, M.P., Méresse, S., Delorme, J., Fruchart, J.C. & Cecchelii, R. (1990). An easier reproducible and mass-production method to study the blood-brain barrier "in vitro". Journal of Neurochemistry 54, 1798-1801.
64. Veronesi, B. Characterization of the Madin-Darby canine kidney (MDCK) cell as an in vitro model of the blood-brain barrier. Neurotoxicology, in press.
65. Wilkinson, G.R. (1987). Clearance approaches in pharmacology. Pharmacological Reviews 39, 1-47.
66. Boxenbaum, H. (1980). Interspecies variation in liver weight, hepatic blood flow and antipyrine intrinsic clearance: extrapolation of data to benzodiazepines and phenytoin. Journal of Biokinetics and Biopharmaceutics 8, 165-176.
67. Houston, J.B. (1994). Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance. Biochemical Pharmacology 47, 1469-1479.
68. Worboys, P.D., Bradbury, A. & Houston, J.B. (1995). Kinetics of drug metabolism in rat liver slices. Drug Metabolism and Disposition 23, 393-397.
69. Kedderis, G.L., Carfagna, M.A., Held, S.D., Bartra, R., Murphy, J.E & Gargas, M.L. (1993). Kinetic analysis of furan biotransformation by F 334 rats in vivo and in vitro. Toxicology and Applied Pharmacology 123, 274-282.
70. Kedderis, G.L., Held, S.D. & Gargas, M.L. (1993). Prediction of chemical pharmacokinetics in vivo using freshly isolated hepatocytes in vitro. ISSX Proceedings 4, 61.
71. Kedderis, G.L , Held, S D. & Bartra, R. (1995). Kinetics of acrylonitrile biotransformation by isolated rat hepatocytes. The Toxicologist 15, 283-284.
72. Bayliss, M.K., Bell, J A, Jenner, W.N & Wilson, K. (1990). The prediction of the intrinsic clearance of loxtidine from kinetic studies in rat, dog and human hepatocytes. Biochemical Society Transactions 18, 1198-1199.
73. Gargas, M.L., Andersen, M.E. & Clewell, H.J. 3rd (1986). A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicology and Applied Pharmacology 86, 341-352.
74. Gargas, M.L., Kedderis, G.L., Fennell, T.R. & Andersen, M.E. (1990). A physiologically based biokinetic (PBPK) model for acrylonitrile (ACN) in the rat. The Toxicologist 10, 216.
75. Evelo, C.T.A., Oostendorp, J.G.M., Ten Berge, W.F. & Borm, P.J.A. (1993). Physiologically based toxicokinetic modelling of 1,3-butadine: lung metabolism becomes more important at low doses. Environmental Health Perspectives 101. 496-502.
76. Rauws, A.G & Groen, K. (1994). Future perspectives on toxicokinetics: a regulator's view. Drug Information Journal 28, 295-300.
77. Gülden M., Seibert, H. & Voss J-U. (1994). Inclusion of physicochemical data in quantitative comparisons of in vitro and in vivo toxic potencies. ATLA 22, 185-192.
78. Bondesson, I., Ekwall, B., Hellberg, S., Romert, L., Stenberg, K., & Walum, E (1989). MEIC: a new international multicenter project to evaluate the relevance to human toxicity of in vitro cytotoxicity tests. Cell Biology and Toxicology 5, 331-347.
79. Gülden, M , Seibert H. & Voss, J-U. (1994). The use of cultured skeletal muscle cells in testing for acute systemic toxicity. Toxicology in Vitro 8, 779-782.
80. Seibert, H., Gülden, M. & Voss, J-U. (1994). An in vitro testing strategy for the classification and labelling of chemicals according to their potential acute lethal potency. Toxicology in Vitro 8, 847-850.
81. Reitz, R.H , Mendrala, A.L., Corley, T.A , Quast. J.F., Gargas, M.L., Andersen, M.E., Staats, D.A. & Conolly, R.B. (1990). Estimating the risk of liver cancer associated with human exposures to chloroform using physiologically based pharmacokinetic modelling. Toxicology and Applied Pharmacology 105, 443-459.
82. Beck, B.D., Conolly, R.B., Dourson, M.L., Guth, D., Hattis, D., Kimmel, C. & Lewis, S.C. (1993). Improvements in quantitative non-cancer risk assessment. Fundamental and Applied Toxicology 20, 1-14.